Healthcare
Ceresti Health – SUCCESS PAGE – January 27, 2025
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively without opioids.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively without opioids.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Alzheon is a clinical-stage biopharma company with a first-in-class oral treatment targeting the root cause of Alzheimer’s disease.
Alzheon is a clinical-stage biopharma company with a first-in-class oral treatment targeting the root cause of Alzheimer’s disease.
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2025 FORCE Family Office
